MedPath

Study of the body fat-reducing effect of the 12-week intake of food containing lactic acid bacteria: A randomized, double-blind, placebo-controlled, parallel-group study

Phase 2
Conditions
Overweight
Registration Number
JPRN-UMIN000027709
Lead Sponsor
KSO Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1)Subjects with severe onset of obesity-related disease (impaired glucose tolerance, dyslipidemia, hypertension, hyperuricemia, coronary artery disease, cerebral infarction, fatty liver, menstrual disorder and pregnancy complications, sleep apnea syndrome or obesity hypoventilation syndrome, orthopedic surgery, obesity-related kidney disease) 2)Subjects with food allergy or lactose intolerance 3)Subjects with a habit of intake more than twice in a week of fermented milk or lactic fermenting beverage in three months before screening test 4)Subjects with a habit of oral medication, supplements, health food affecting obesity, hyperlipidemia, glucese or lipid matabolism in three months before screening test, and subjects who will take these in the test period. 5)Subjects who are regularly practicing intense exercise (exercising for the purpose of muscle strengthening, attending exercise facilities more than three times in a week, etc.) 6)Subjects who have been drug dependency or alcohol dependency 7)Subjects who drink a lot of alcohol, and subjects who can not abstain from drinking from two days before the examination date 8)Subjects who have metal in the measurement site of CT scan 9)Subjects who contain cardiac pacemaker, implantable defibrillator 10)Subjects who have been diagnosed with familial hyperlipemia 11)Subjects in pregnancy or in nursing 12)Subjects whose eating habits are extremely irregulae (ex. midnight and irregulae shift worker) 13)Subjects who participated in other clinical trials within one month before the agreement of participants in this study 14)Subjects with claustrophobia 15)Subjects who are judged as unsuitable for the study by the investigator for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath